Showing results (111-120 of 2,459) with videos related to

Sort By:
Pageof 246
Journal of Virology|December 19, 2008
Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivoW David Wick, Peter B Gilbert, Otto O Yang
Immunity|August 17, 2004
Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptorsChyi-Song Hsieh, Yuqiong Liang, Aaron J Tyznik, et al.
Biometrics|August 22, 2006
Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trialsBryan E Shepherd, Peter B Gilbert, Yannis Jemiai, et al.
Journal of the Royal Statistical Society. Series B, Statistical Methodology|March 16, 2010
Semiparametric estimation of treatment effects given base-line covariates on an outcome measured after a post-randomization event occursYannis Jemiai, Andrea Rotnitzky, Bryan E Shepherd, et al.
Biometrics|October 12, 2020
Nonparametric variable importance assessment using machine learning techniquesBrian D Williamson, Peter B Gilbert, Marco Carone, et al.
Computational Statistics & Data Analysis|June 13, 2018
Analysis of Generalized Semiparametric Regression Models for Cumulative Incidence Functions with Missing CovariatesUnkyung Lee, Yanqing Sun, Thomas H Scheike, et al.
BMC Bioinformatics|October 18, 2017
chngpt: threshold regression model estimation and inferenceYouyi Fong, Ying Huang, Peter B Gilbert, et al.
Vaccine|November 22, 2008
Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trialsPeter B Gilbert, Alicia Sato, Xiao Sun, et al.
Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|August 23, 2024
A framework for leveraging machine learning tools to estimate personalized survival curvesCharles J Wolock, Peter B Gilbert, Noah Simon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rateDonald N Forthal, Peter B Gilbert, Gary Landucci, et al.
Pageof 246